Loading...
Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma
Appreciation for genomic and immune heterogeneity in cancer has grown though the relationship of these factors to treatment response has not been thoroughly elucidated. To better understand this, we studied a large cohort of melanoma patients treated with targeted therapy or immune checkpoint blocka...
Saved in:
| Published in: | NPJ Genom Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Nature Publishing Group UK
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5557036/ https://ncbi.nlm.nih.gov/pubmed/28819565 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41525-017-0013-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|